Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Reversal of drug-resistant falciparum malaria by calcium antagonists: Potential for host cell toxicity

Identifieur interne : 003010 ( Main/Exploration ); précédent : 003009; suivant : 003011

Reversal of drug-resistant falciparum malaria by calcium antagonists: Potential for host cell toxicity

Auteurs : George Watt [États-Unis] ; Gary W. Long [États-Unis] ; Max Grogl [États-Unis] ; Samuel K. Martin [États-Unis]

Source :

RBID : ISTEX:961110AADFC63244EE63ECDDBF963F756AB658B3

English descriptors

Abstract

Agents capable of reversing multidrug resistance (mdr) in falciparum malaria were investigated for potentiation of chloroquine accumulation and toxicity in a cell culture system. Verapamil, its analog RO11-2933, and desipramine caused a dose-dependent increase in the accumulation of chloroquine (CQ) within human and mouse hepatocytes but not human lung cells. Only those cells in which drug accumulation was enhanced by reversing agents reacted positively for P-glycoprotein (PgP)—the putative mediator of the enhanced drug efflux characteristic of mdr. Clinically achievable concentrations of verapamil (0·4 μM) and desipramine (1 μm) increased CQ accumulation within primary mouse hepatocytes by more than 50%. A well-differentiated normal human cell line (Hep-G2) was killed in media containing a combination of supraphysiological concentrations of CQ and verapamil but survived the same concentrations of either drug alone. Reversing agents may block PgP-mediated drug export from normal tissues as well as from MDR cells. Iatrogenic toxicity resulting from this accumulation of potentially toxic drugs such as CQ within normal cells could complicate the reversal of mdr in vivo.

Url:
DOI: 10.1016/0035-9203(90)90248-D


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Reversal of drug-resistant falciparum malaria by calcium antagonists: Potential for host cell toxicity</title>
<author>
<name sortKey="Watt, George" sort="Watt, George" uniqKey="Watt G" first="George" last="Watt">George Watt</name>
</author>
<author>
<name sortKey="Long, Gary W" sort="Long, Gary W" uniqKey="Long G" first="Gary W." last="Long">Gary W. Long</name>
</author>
<author>
<name sortKey="Grogl, Max" sort="Grogl, Max" uniqKey="Grogl M" first="Max" last="Grogl">Max Grogl</name>
</author>
<author>
<name sortKey="Martin, Samuel K" sort="Martin, Samuel K" uniqKey="Martin S" first="Samuel K." last="Martin">Samuel K. Martin</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:961110AADFC63244EE63ECDDBF963F756AB658B3</idno>
<date when="1990" year="1990">1990</date>
<idno type="doi">10.1016/0035-9203(90)90248-D</idno>
<idno type="url">https://api.istex.fr/ark:/67375/HXZ-SDBMPJWT-V/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000B44</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000B44</idno>
<idno type="wicri:Area/Istex/Curation">000B44</idno>
<idno type="wicri:Area/Istex/Checkpoint">001D80</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001D80</idno>
<idno type="wicri:doubleKey">0035-9203:1990:Watt G:reversal:of:drug</idno>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6EAC58EC0FAF6FE93600B3AF3A7A275901BBCD45</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-5LWH9G0G-B/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000972</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000972</idno>
<idno type="wicri:Area/Istex/Curation">000972</idno>
<idno type="wicri:Area/Istex/Checkpoint">001D79</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001D79</idno>
<idno type="wicri:doubleKey">0035-9203:1990:Watt G:reversal:of:drug</idno>
<idno type="wicri:Area/Main/Merge">003079</idno>
<idno type="wicri:Area/Main/Curation">003010</idno>
<idno type="wicri:Area/Main/Exploration">003010</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Reversal of drug-resistant falciparum malaria by calcium antagonists: Potential for host cell toxicity</title>
<author>
<name sortKey="Watt, George" sort="Watt, George" uniqKey="Watt G" first="George" last="Watt">George Watt</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Hematology, Division of Medicine, Walter Reed Army Institute of Research, Washington, DC</wicri:regionArea>
<placeName>
<region type="state">District de Columbia</region>
</placeName>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Current address and address for correspondence: Dr George Watt, Department of Medicine, AFRIMS, APO San Francisco, CA 96346-5000</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Long, Gary W" sort="Long, Gary W" uniqKey="Long G" first="Gary W." last="Long">Gary W. Long</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Malaria Division, Infectious Diseases Department, Naval Medical Research Institute, Bethesda, Maryland</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Grogl, Max" sort="Grogl, Max" uniqKey="Grogl M" first="Max" last="Grogl">Max Grogl</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Parasitology, Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Washington, DC</wicri:regionArea>
<placeName>
<region type="state">District de Columbia</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Martin, Samuel K" sort="Martin, Samuel K" uniqKey="Martin S" first="Samuel K." last="Martin">Samuel K. Martin</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Hematology, Division of Medicine, Walter Reed Army Institute of Research, Washington, DC</wicri:regionArea>
<placeName>
<region type="state">District de Columbia</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Transactions of The Royal Society of Tropical Medicine and Hygiene</title>
<title level="j" type="abbrev">Trans R Soc Trop Med Hyg</title>
<idno type="ISSN">0035-9203</idno>
<idno type="eISSN">1878-3503</idno>
<imprint>
<publisher>Royal Society of Tropical Medicine and Hygiene</publisher>
<date when="1990-03">1990</date>
<biblScope unit="vol">84</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="187">187</biblScope>
<biblScope unit="page" to="190">190</biblScope>
</imprint>
<idno type="ISSN">0035-9203</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0035-9203</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Annual subscription</term>
<term>Calcium antagonists</term>
<term>Cell line</term>
<term>Cell lines</term>
<term>Chloroquine</term>
<term>Chloroquine resistance</term>
<term>Culture medium</term>
<term>Cytoplasmic domain</term>
<term>Desipramine</term>
<term>Drug accumulation</term>
<term>Excretory function</term>
<term>Gottesman</term>
<term>Hepatocytes</term>
<term>Human cells</term>
<term>Iatrogenic toxicity</term>
<term>Lung cells</term>
<term>Microtitre plates</term>
<term>Monoclonal antibodies</term>
<term>Mouse hepatocytes</term>
<term>Multidrug resistance</term>
<term>National academy</term>
<term>Normal cells</term>
<term>Pastan</term>
<term>Positive control cells</term>
<term>Primary mouse hepatocytes</term>
<term>Reversal</term>
<term>Royal society</term>
<term>Second antibody</term>
<term>Supraphysiological concentrations</term>
<term>Toxicity</term>
<term>Tropical medicine</term>
<term>Verapamil</term>
<term>Walter reed army institute</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Agents capable of reversing multidrug resistance (mdr) in falciparum malaria were investigated for potentiation of chloroquine accumulation and toxicity in a cell culture system. Verapamil, its analog RO11-2933, and desipramine caused a dose-dependent increase in the accumulation of chloroquine (CQ) within human and mouse hepatocytes but not human lung cells. Only those cells in which drug accumulation was enhanced by reversing agents reacted positively for P-glycoprotein (PgP)—the putative mediator of the enhanced drug efflux characteristic of mdr. Clinically achievable concentrations of verapamil (0·4 μM) and desipramine (1 μm) increased CQ accumulation within primary mouse hepatocytes by more than 50%. A well-differentiated normal human cell line (Hep-G2) was killed in media containing a combination of supraphysiological concentrations of CQ and verapamil but survived the same concentrations of either drug alone. Reversing agents may block PgP-mediated drug export from normal tissues as well as from MDR cells. Iatrogenic toxicity resulting from this accumulation of potentially toxic drugs such as CQ within normal cells could complicate the reversal of mdr in vivo.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
<li>District de Columbia</li>
<li>Maryland</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="District de Columbia">
<name sortKey="Watt, George" sort="Watt, George" uniqKey="Watt G" first="George" last="Watt">George Watt</name>
</region>
<name sortKey="Grogl, Max" sort="Grogl, Max" uniqKey="Grogl M" first="Max" last="Grogl">Max Grogl</name>
<name sortKey="Long, Gary W" sort="Long, Gary W" uniqKey="Long G" first="Gary W." last="Long">Gary W. Long</name>
<name sortKey="Martin, Samuel K" sort="Martin, Samuel K" uniqKey="Martin S" first="Samuel K." last="Martin">Samuel K. Martin</name>
<name sortKey="Watt, George" sort="Watt, George" uniqKey="Watt G" first="George" last="Watt">George Watt</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003010 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003010 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:961110AADFC63244EE63ECDDBF963F756AB658B3
   |texte=   Reversal of drug-resistant falciparum malaria by calcium antagonists: Potential for host cell toxicity
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021